Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Dermapharm Holding SE buy Shooter

Start price
€47.68
16.05.23 / 50%
Target price
-
16.05.24
Performance (%)
-34.14%
Price
€31.40
16:53
Summary
This prediction is currently active. The BUY prediction by Shooter for Dermapharm Holding SE is performing very badly with a performance of -34.14%. This prediction currently runs until 16.05.24. The prediction end date can be changed by Shooter at any time. Shooter has 50% into this prediction

Dermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.

Performance without dividends (%)
Name 1w 1m
Dermapharm Holding SE -4.970% -4.970%
iShares Core DAX® 0.961% -2.210%
iShares Nasdaq 100 2.626% -1.918%
iShares Nikkei 225® 0.217% -7.216%
iShares S&P 500 1.540% -1.858%

Comments by Shooter for this prediction